Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Radant Lite** is a topical skin-lightening and depigmenting product line developed by Percos, which includes **Radant Lite Cream** and **Radant Lite Masque**. Radant Lite Cream is a synergistic formulation containing hydroquinone (2%), arbutin, kojic acid, lactic acid, grape seed oil, and Antipollon HT (a synthesized aluminum silicate). It is primarily indicated for the treatment of melasma, hyperpigmentation, dark spots, and uneven skin tone. The cream works by inhibiting the tyrosinase enzyme to reduce melanin synthesis, while Antipollon HT physically adsorbs surface melanin. Radant Lite Masque is a peel-off formulation containing arbutin, kojic acid, and Antipollon HT, designed to exfoliate dead skin cells and provide instant skin brightening.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Radant Lite.